Molecular and clinical features of chronic lymphocytic leukaemia with stereotyped B cell receptors: Results from an Italian multicentre study

British Journal of Haematology

Volumn 144, Issue 4, 2009, Pages 492-506

  Bomben, Riccardo ^a   Dal Bo, Michele ^a   Capello, Daniela ^b   Forconi, Francesco ^c   Maffei, Rossana ^d   Laurenti, Luca ^e   Rossi, Davide ^b   Del Principe, Maria Ilaria ^f   Zucchetto, Antonella ^a   Bertoni, Francesco ^g   Rossi, Francesca Maria ^a   Bulian, Pietro ^a   Cattarossi, Ilaria ^a   Ilariucci, Fiorella ^h   Sozzi, Elisa ^c   Spina, Valeria ^b   Zucca, Emanuele ^g   Degan, Massimo ^a   Lauria, Francesco ^c   Del Poeta, Giovanni ^f   Efremov, Dimitar G ⁱ   Marasca, Roberto ^d   Gaidano, Gianluca ^b   Gattei, Valter ^a   more..

^a CENTRO DI RIFERIMENTO ONCOLOGICO   (Italy)

^b UNIVERSITY OF EASTERN PIEDMONT   (Italy)

^c UNIVERSITY OF SIENA   (Italy)

^d UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

^e CATHOLIC UNIVERSITY   (Italy)

^f UNIVERSITY OF ROME TOR VERGATA   (Italy)

^g ONCOLOGY INSTITUTE OF SOUTHERN SWITZERLAND   (Switzerland)

^h UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

ⁱ ICGEB Outstation Monterotondo   (Italy)

Author keywords

B cell receptor; Chronic lymphocytic leukaemia; Immunoglobulin genes; Prognosis

Indexed keywords

B LYMPHOCYTE RECEPTOR; IMMUNOGLOBULIN;

ADULT; AGED; ARTICLE; CHRONIC LYMPHATIC LEUKEMIA; CLINICAL FEATURE; CONTROLLED STUDY; HUMAN; MAJOR CLINICAL STUDY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROGNOSIS; PROTEIN ANALYSIS; SOMATIC MUTATION; STEREOTYPY;

ADULT; AGED; AGED, 80 AND OVER; CHROMOSOME ABERRATIONS; COMPLEMENTARITY DETERMINING REGIONS; FOLLOW-UP STUDIES; GENE EXPRESSION REGULATION, LEUKEMIC; GENE REARRANGEMENT, B-LYMPHOCYTE; GENES, IMMUNOGLOBULIN HEAVY CHAIN; HUMANS; IMMUNOGLOBULIN HEAVY CHAINS; IMMUNOGLOBULIN VARIABLE REGION; IMMUNOPHENOTYPING; LEUKEMIA, LYMPHOCYTIC, CHRONIC, B-CELL; MIDDLE AGED; PROGNOSIS; RECEPTORS, ANTIGEN, B-CELL; SOMATIC HYPERMUTATION, IMMUNOGLOBULIN; TIME FACTORS;

EID: 58549100059     PISSN: 00071048     EISSN: 13652141     Source Type: Journal    
DOI: 10.1111/j.1365-2141.2008.07469.x     Document Type: Article

References (71)

1. Bomben, R., Dal Bo, M., Capello, D., Benedetti, D., Marconi, D., Zucchetto, A., Forconi, F., Maffei, R., Ghia, E.M., Laurenti, L., Bulian, P., Del Principe, M.I., Palermo, G., Thorselius, M., Degan, M., Campanini, R., Guarini, A., Del Poeta, G., Rosenquist, R., Efremov, D.G., Marasca, R., Foa, R., Gaidano, G. Gattei, V. (2007) Comprehensive characterization of IGHV3-21-expressing B-cell chronic lymphocytic leukemia: an Italian multicenter study. Blood, 109, 2989 2998.
2. Borche, L., Lim, A., Binet, J.L. Dighiero, G. (1990) Evidence that chronic lymphocytic leukemia B lymphocytes are frequently committed to production of natural autoantibodies. Blood, 76, 562 569.
3. Capello, D., Guarini, A., Berra, E., Mauro, F.R., Rossi, D., Ghia, E., Cerri, M., Logan, J., Foa, R. Gaidano, G. (2004) Evidence of biased immunoglobulin variable gene usage in highly stable B-cell chronic lymphocytic leukemia. Leukemia, 18, 1941 1947.
4. Capello, D., Zucchetto, A., Degan, M., Bomben, R., Dal Bo, M., Efremov, D.G., Laurenti, L., Del Poeta, G., Gaidano, G. Gattei, V. (2006) Immunophenotypic characterization of IgVH3-72 B-cell chronic lymphocytic leukaemia (B-CLL). Leukemia Research, 30, 1197 1199.
5. Cheson, B.D., Bennett, J.M., Grever, M., Kay, N., Keating, M.J., O'Brien, S. Rai, K.R. (1996) National Cancer Institute-sponsored Working Group guidelines for chronic lymphocytic leukemia: revised guidelines for diagnosis and treatment. Blood, 87, 4990 4997.
6. Chiorazzi, N. Ferrarini, M. (2003) Chronic lymphocytic leukemia: lessons learned from studies of the B cell antigen receptor. Annual Review of Immunology, 21, 841 894.
7. Chiorazzi, N., Rai, K.R. Ferrarini, M. (2005) Chronic lymphocytic leukemia. The New England Journal of Medicine, 352, 804 815.
8. Crespo, M., Bosch, F., Villamor, N., Bellosillo, B., Colomer, D., Rozman, M., Marce, S., Lopez-Guillermo, A., Campo, E. Montserrat, E. (2003) ZAP-70 expression as a surrogate for immunoglobulin-variable-region mutations in chronic lymphocytic leukemia. The New England Journal of Medicine, 348, 1764 1775.
9. Damle, R.N., Wasil, T., Fais, F., Ghiotto, F., Valetto, A., Allen, S.L., Buchbinder, A., Budman, D., Dittmar, K., Kolitz, J., Lichtman, S.M., Schulman, P., Vinciguerra, V.P., Rai, K.R., Ferrarini, M. Chiorazzi, N. (1999) Ig V gene mutation status and CD38 expression as novel prognostic indicators in chronic lymphocytic leukemia. Blood, 94, 1840 1847.
10. Degan, M., Bomben, R., Dal Bo, M., Zucchetto, A., Nanni, P., Rupolo, M., Steffan, A., Attadia, V., Ballerini, P.F., Damiani, D., Pucillo, C., Del Poeta, G., Colombatti, A. Gattei, V. (2004a) Analysis of IgVH gene mutations in B-CLL according to antigen-driven selection identifies subgroups with different prognosis and usage of the canonical SHM machinery. British Journal of Haematology, 126, 29 42.
11. Degan, M., Rupolo, M., Dal Bo, M., Stefanon, A., Bomben, R., Zucchetto, A., Canton, E., Berretta, M., Nanni, P., Steffan, A., Ballerini, P.F., Damiani, D., Pucillo, C., Attadia, V., Colombatti, A. Gattei, V. (2004b) Mutational status of IgVH genes consistent with antigen-driven selection but not percent of mutations has prognostic impact in B-cell chronic lymphocytic leukemia. Clinical Lymphoma, 5, 123 126.
12. Del Poeta, G., Maurillo, L., Venditti, A., Buccisano, F., Epiceno, A.M., Capelli, G., Tamburini, A., Suppo, G., Battaglia, A., Del Principe, M.I., Del Moro, B., Masi, M. Amadori, S. (2001) Clinical significance of CD38 expression in chronic lymphocytic leukemia. Blood, 98, 2633 2639.
13. Del Poeta, G., Del Principe, M.I., Consalvo, M.A., Maurillo, L., Buccisano, F., Venditti, A., Mazzone, C., Bruno, A., Gianni, L., Capelli, G., Lo, C.F., Cantonetti, M., Gattei, V. Amadori, S. (2005) The addition of rituximab to fludarabine improves clinical outcome in untreated patients with ZAP-70-negative chronic lymphocytic leukemia. Cancer, 104, 2743 2752.
14. Del Principe, M.I., Del Poeta, G., Venditti, A., Buccisano, F., Maurillo, L., Marini, R., Cox, M.C., Panetta, P., Suppo, G., Degan, M., Bruno, A., Gattei, V. Amadori, S. (2004) Clinical significance of soluble p53 protein in B-cell chronic lymphocytic leukemia. Haematologica, 89, 1468 1475.
15. Del Principe, M.I., Del Poeta, G., Buccisano, F., Maurillo, L., Venditti, A., Zucchetto, A., Marini, R., Niscola, P., Consalvo, M.A.I., Mazzone, C., Ottaviani, L., Panetta, P., Bruno, A., Bomben, R., Suppo, G., Degan, M., Gattei, V., de Fabritiis, P., Cantonetti, M., Lo Coco, F., Del Principe, D. Amadori, S. (2006) Clinical significance of ZAP-70 protein expression in B-cell chronic lymphocytic leukemia. Blood, 108, 853 861.
16. Dighiero, G., Guilbert, B., Fermand, J.P., Lymberi, P., Danon, F. Avrameas, S. (1983) Thirty-six human monoclonal immunoglobulins with antibody activity against cytoskeleton proteins, thyroglobulin, and native DNA: immunologic studies and clinical correlations. Blood, 62, 264 270.
17. Dohner, H., Stilgenbauer, S., Benner, A., Leupolt, E., Krober, A., Bullinger, L., Dohner, K., Bentz, M. Lichter, P. (2000) Genomic aberrations and survival in chronic lymphocytic leukemia. The New England Journal of Medicine, 343, 1910 1916.
18. Domiati-Saad, R. Lipsky, P.E. (1998) Staphylococcal enterotoxin A induces survival of VH3-expressing human B cells by binding to the VH region with low affinity. Journal of Immunology, 161, 1257 1266.
19. Durig, J., Naschar, M., Schmucker, U., Renzing-Kohler, K., Holter, T., Huttmann, A. Duhrsen, U. (2002) CD38 expression is an important prognostic marker in chronic lymphocytic leukaemia. Leukemia, 16, 30 35.
20. Durig, J., Nuckel, H., Cremer, M., Fuhrer, A., Halfmeyer, K., Fandrey, J., Moroy, T., Klein-Hitpass, L. Duhrsen, U. (2003) ZAP-70 expression is a prognostic factor in chronic lymphocytic leukemia. Leukemia, 17, 2426 2434.
21. Fais, F., Ghiotto, F., Hashimoto, S., Sellars, B., Valetto, A., Allen, S.L., Schulman, P., Vinciguerra, V.P., Rai, K., Rassenti, L.Z., Kipps, T.J., Dighiero, G., Schroeder, H.W., Jr., Ferrarini, M. Chiorazzi, N. (1998) Chronic lymphocytic leukemia B cells express restricted sets of mutated and unmutated antigen receptors. Journal of Clinical Investigation, 102, 1515 1525.
22. Gattei, V., Bulian, P., Del Principe, M.I., Zucchetto, A., Maurillo, L., Buccisano, F., Bomben, R., Dal-Bo, M., Luciano, F., Rossi, F.M., Degan, M., Amadori, S. Del, P.G. (2008) Relevance of CD49d protein expression as overall survival and progressive disease prognosticator in chronic lymphocytic leukemia. Blood, 111, 865 873.
23. Ghia, P., Stamatopoulos, K., Belessi, C., Moreno, C., Stella, S., Guida, G., Michel, A., Crespo, M., Laoutaris, N., Montserrat, E., Anagnostopoulos, A., Dighiero, G., Fassas, A., Caligaris-Cappio, F. Davi, F. (2005) Geographic patterns and pathogenetic implications of IGHV gene usage in chronic lymphocytic leukemia: the lesson of the IGHV3-21 gene. Blood, 105, 1678 1685.
24. Ghia, E.M., Jain, S., Widhopf, G.F., Rassenti, L.Z., Keating, M.J., Wierda, W.G., Gribben, J.G., Brown, J.R., Rai, K.R., Byrd, J.C., Kay, N.E., Greaves, A.W. Kipps, T.J. (2008) Use of IGHV3-21 in chronic lymphocytic leukemia is associated with high-risk disease and reflects antigen-driven, post-germinal-center leukemogenic selection. Blood, 111, 5101 5108.
25. Ghiotto, F., Fais, F., Valetto, A., Albesiano, E., Hashimoto, S., Dono, M., Ikematsu, H., Allen, S.L., Kolitz, J., Rai, K.R., Nardini, M., Tramontano, A., Ferrarini, M. Chiorazzi, N. (2004) Remarkably similar antigen receptors among a subset of patients with chronic lymphocytic leukemia. Journal of Clinical Investigation, 113, 1008 1016.
26. Giudicelli, V., Chaume, D. Lefranc, M.P. (2004) IMGT/V-QUEST, an integrated software program for immunoglobulin and T cell receptor V-J and V-D-J rearrangement analysis. Nucleic Acids Research, 32, W435 W440.
27. Guarini, A., Gaidano, G., Mauro, F.R., Capello, D., Mancini, F., De Propris, M.S., Mancini, M., Orsini, E., Gentile, M., Breccia, M., Cuneo, A., Castoldi, G. Foa, R. (2003) Chronic lymphocytic leukemia patients with highly stable and indolent disease show distinctive phenotypic and genotypic features. Blood, 102, 1035 1041.
28. Hamblin, T.J., Davis, Z., Gardiner, A., Oscier, D.G. Stevenson, F.K. (1999) Unmutated Ig V(H) genes are associated with a more aggressive form of chronic lymphocytic leukemia. Blood, 94, 1848 1854.
29. Hamblin, T.J., Orchard, J.A., Gardiner, A., Oscier, D.G., Davis, Z. Stevenson, F.K. (2000) Immunoglobulin V genes and CD38 expression in CLL. Blood, 95, 2455 2457.
30. Hamblin, T., Orchard, J.A., Ibbotson, R.E., Davis, Z., Thomas, P.W., Stevenson, F.K. Oscier, D.G. (2002) CD38 expression and immunoglobulin variable region mutations are independent prognostic variables in chronic lymphocytic leukemia, but CD38 expression may vary during the course of the disease. Blood, 99, 1023 1029.
31. Herve, M., Xu, K., Ng, Y.S., Wardemann, H., Albesiano, E., Messmer, B.T., Chiorazzi, N. Meffre, E. (2005) Unmutated and mutated chronic lymphocytic leukemias derive from self-reactive B cell precursors despite expressing different antibody reactivity. Journal of Clinical Investigation, 115, 1636 1643.
32. Honegger, A. Pluckthun, A. (2001) Yet another numbering scheme for immunoglobulin variable domains: an automatic modeling and analysis tool. Journal of Molecular Biology, 309, 657 670.
33. Johnson, T.A., Rassenti, L.Z. Kipps, T.J. (1997) Ig VH1 genes expressed in B cell chronic lymphocytic leukemia exhibit distinctive molecular features. Journal of Immunology, 158, 235 246.
34. Krober, A., Seiler, T., Benner, A., Bullinger, L., Bruckle, E., Lichter, P., Dohner, H. Stilgenbauer, S. (2002) VH mutational status, CD38 expression level, genomic aberrations, and survival in chronic lymphocytic leukemia. Blood, 1000, 1410 1416.
35. Krober, A., Bloehdorn, J., Hafner, S., Buhler, A., Seiler, T., Kienle, D., Winkler, D., Bangerter, M., Schlenk, R.F., Benner, A., Lichter, P., Dohner, H. Stilgenbauer, S. (2006) Additional genetic high-risk features such as 11q deletion, 17p deletion, and V3-21 usage characterize discordance of ZAP-70 and VH mutation status in chronic lymphocytic leukemia. Journal of Clinical Oncology, 24, 969 975.
36. Lanemo Myhrinder, A., Hellqvist, E., Sidorova, E., Soderberg, A., Baxendale, H., Dahle, C., Willander, K., Tobin, G., Backman, E., Soderberg, O., Rosenquist, R., Horkko, S. Rosen, A. (2008) A new perspective: molecular motifs on oxidized LDL, apoptotic cells, and bacteria are targets for chronic lymphocytic leukemia antibodies. Blood, 111, 3838 3848.
37. Lefranc, M.P., Giudicelli, V., Kaas, Q., Duprat, E., Jabado-Michaloud, J., Scaviner, D., Ginestoux, C., Clement, O., Chaume, D. Lefranc, G. (2005) IMGT, the international ImMunoGeneTics information system. Nucleic Acids Research, 33, D593 D597.
38. Maccallum, R.M., Martin, A.C. Thornton, J.M. (1996) Antibody-antigen interactions: contact analysis and binding site topography. Journal of Molecular Biology, 262, 732 745.
39. Marasca, R., Vaccari, P., Luppi, M., Zucchini, P., Castelli, I., Barozzi, P., Cuoghi, A. Torelli, G. (2001) Immunoglobulin gene mutations and frequent use of VH1-69 and VH4-34 segments in hepatitis C virus-positive and hepatitis C virus-negative nodal marginal zone B-cell lymphoma. American Journal of Pathology, 159, 253 261.
40. Martin, T., Duffy, S.F., Carson, D.A. Kipps, T.J. (1992) Evidence for somatic selection of natural autoantibodies. Journal of Experimental Medicine, 175, 983 991.
41. Messmer, B.T., Albesiano, E., Messmer, D. Chiorazzi, N. (2004a) The Pattern and distribution of immunoglobulin VH gene mutations in chronic lymphocytic leukemia B cells are consistent with the canonical somatic hypermutation process. Blood, 103, 3490 3495.
42. Messmer, B.T., Albesiano, E., Efremov, D.G., Ghiotto, F., Allen, S.L., Kolitz, J., Foa, R., Damle, R.N., Fais, F., Messmer, D., Rai, K.R., Ferrarini, M. Chiorazzi, N. (2004b) Multiple distinct sets of stereotyped antigen receptors indicate a role for antigen in promoting chronic lymphocytic leukemia. Journal of Experimental Medicine, 200, 519 525.
43. Murray, F., Darzentas, N., Hadzidimitriou, A., Tobin, G., Boudjogra, M., Scielzo, C., Laoutaris, N., Karlsson, K., Baran-Marzsak, F., Tsaftaris, A., Moreno, C., Anagnostopoulos, A., Caligaris-Cappio, F., Vaur, D., Ouzounis, C., Belessi, C., Ghia, P., Davi, F., Rosenquist, R. Stamatopoulos, K. (2008) Stereotyped patterns of somatic hypermutation in subsets of patients with chronic lymphocytic leukemia: implications for the role of antigen selection in leukemogenesis. Blood, 111, 1524 1533.
44. Orchard, J.A., Ibbotson, R.E., Davis, Z., Wiestner, A., Rosenwald, A., Thomas, P.W., Hamblin, T.J., Staudt, L.M. Oscier, D.G. (2004) ZAP-70 expression and prognosis in chronic lymphocytic leukaemia. Lancet, 363, 105 111.
45. Panovska-Stavridis, I., Ivanovski, M., Siljanovski, N., Cevreska, L. Efremov, D.G. (2007) Chronic lymphocytic leukemia patients with a V1-69 gene rearrangement do not have inferior survival with respect to patients that express other unmutated V(H) genes. Leukemia Research, 31, 245 248.
46. Pommie, C., Levadoux, S., Sabatier, R., Lefranc, G. Lefranc, M.P. (2004) IMGT standardized criteria for statistical analysis of immunoglobulin V-REGION amino acid properties. Journal of Molecular Recognition, 17, 17 32.
47. Rai, K.R., Sawitsky, A., Cronkite, E.P., Chanana, A.D., Levy, R.N. Pasternack, B.S. (1975) Clinical staging of chronic lymphocytic leukemia. Blood, 46, 219 234.
48. Rassenti, L.Z. Kipps, T.J. (1997) Lack of allelic exclusion in B cell chronic lymphocytic leukemia. Journal of Experimental Medicine, 185, 1435 1445.
49. Rassenti, L.Z., Huynh, L., Toy, T.L., Chen, L., Keating, M.J., Gribben, J.G., Neuberg, D.S., Flinn, I.W., Rai, K.R., Byrd, J.C., Kay, N.E., Greaves, A., Weiss, A. Kipps, T.J. (2004) ZAP-70 compared with immunoglobulin heavy-chain gene mutation status as a predictor of disease progression in chronic lymphocytic leukemia. The New England Journal of Medicine, 351, 893 901.
50. Rosenquist, R., Lindstrom, A., Holmberg, D., Lindh, J. Roos, G. (1999) V(H) gene family utilization in different B-cell lymphoma subgroups. European Journal of Haematology, 62, 123 128.
51. Sasso, E.H., Silverman, G.J. Mannik, M. (1989) Human IgM molecules that bind staphylococcal protein A contain VHIII H chains. Journal of Immunology, 142, 2778 2783.
52. Seppala, I., Kaartinen, M., Ibrahim, S. Makela, O. (1990) Mouse Ig coded by VH families S107 or J606 bind to protein A. Journal of Immunology, 145, 2989 2993.
53. Shanafelt, T.D., Geyer, S.M. Kay, N.E. (2004) Prognosis at diagnosis: integrating molecular biologic insights into clinical practice for patients with CLL. Blood, 103, 1202 1210.
54. Silverman, G.J. Goodyear, C.S. (2002) A model B-cell superantigen and the immunobiology of B lymphocytes. Clinical Immunology, 102, 117 134.
55. Silverman, G.J. Goodyear, C.S. (2006) Confounding B-cell defences: lessons from a staphylococcal superantigen. Nature reviews. Immunology, 6, 465 475.
56. Stamatopoulos, K., Belessi, C., Hadzidimitriou, A., Smilevska, T., Kalagiakou, E., Hatzi, K., Stavroyianni, N., Athanasiadou, A., Tsompanakou, A., Papadaki, T., Kokkini, G., Paterakis, G., Saloum, R., Laoutaris, N., Anagnostopoulos, A. Fassas, A. (2005) Immunoglobulin light chain repertoire in chronic lymphocytic leukemia. Blood, 106, 3575 3583.
57. Stamatopoulos, K., Belessi, C., Moreno, C., Boudjograh, M., Guida, G., Smilevska, T., Belhoul, L., Stella, S., Stavroyianni, N., Crespo, M., Hadzidimitriou, A., Sutton, L., Bosch, F., Laoutaris, N., Anagnostopoulos, A., Montserrat, E., Fassas, A., Dighiero, G., Caligaris-Cappio, F., Merle-Beral, H., Ghia, P. Davi, F. (2007) Over 20% of patients with chronic lymphocytic leukemia carry stereotyped receptors: pathogenetic implications and clinical correlations. Blood, 109, 259 270.
58. Stevenson, F.K. Caligaris-Cappio, F. (2004) Chronic lymphocytic leukemia: revelations from the B-cell receptor. Blood, 103, 4389 4395.
59. Sthoeger, Z.M., Wakai, M., Tse, D.B., Vinciguerra, V.P., Allen, S.L., Budman, D.R., Lichtman, S.M., Schulman, P., Weiselberg, L.R. Chiorazzi, N. (1989) Production of autoantibodies by CD5-expressing B lymphocytes from patients with chronic lymphocytic leukemia. Journal of Experimental Medicine, 169, 255 268.
60. Thompson, J.D., Gibson, T.J., Plewniak, F., Jeanmougin, F. Higgins, D.G. (1997) The CLUSTAL-X windows interface: flexible strategies for multiple sequence alignment aided by quality analysis tools. Nucleic Acids Research, 25, 4876 4882.
61. Thorselius, M., Krober, A., Murray, F., Thunberg, U., Tobin, G., Buhler, A., Kienle, D., Albesiano, E., Maffei, R., Dao-Ung, L.P., Wiley, J., Vilpo, J., Laurell, A., Merup, M., Roos, G., Karlsson, K., Chiorazzi, N., Marasca, R., Dohner, H., Stilgenbauer, S. Rosenquist, R. (2006) Strikingly homologous immunoglobulin gene rearrangements and poor outcome in VH3-21-using chronic lymphocytic leukemia patients independent of geographic origin and mutational status. Blood, 107, 2889 2894.
62. Tobin, G., Thunberg, U., Johnson, A., Thorn, I., Soderberg, O., Hultdin, M., Botling, J., Enblad, G., Sallstrom, J., Sundstrom, C., Roos, G. Rosenquist, R. (2002) Somatically mutated Ig V(H)3-21 genes characterize a new subset of chronic lymphocytic leukemia. Blood, 99, 2262 2264.
63. Tobin, G., Thunberg, U., Johnson, A., Eriksson, I., Soderberg, O., Karlsson, K., Merup, M., Juliusson, G., Vilpo, J., Enblad, G., Sundstrom, C., Roos, G. Rosenquist, R. (2003) Chronic lymphocytic leukemias utilizing the VH3-21 gene display highly restricted Vlambda2-14 gene use and homologous CDR3s: implicating recognition of a common antigen epitope. Blood, 101, 4952 4957.
64. Tobin, G., Thunberg, U., Karlsson, K., Murray, F., Laurell, A., Willander, K., Enblad, G., Merup, M., Vilpo, J., Juliusson, G., Sundstrom, C., Soderberg, O., Roos, G. Rosenquist, R. (2004a) Subsets with restricted immunoglobulin gene rearrangement features indicate a role for antigen selection in the development of chronic lymphocytic leukemia. Blood, 104, 2879 2885.
65. Tobin, G., Soderberg, O., Thunberg, U. Rosenquist, R. (2004b) V(H)3-21 gene usage in chronic lymphocytic leukemia - characterization of a new subgroup with distinct molecular features and poor survival. Leukemia & Lymphoma, 45, 221 228.
66. Tschumper, R.C., Geyer, S.M., Campbell, M.E., Kay, N.E., Shanafelt, T.D., Zent, C.S., Nowakowski, G.S., Call, T.G., Dewald, G.W. Jelinek, D.F. (2008) Immunoglobulin diversity gene usage predicts unfavorable outcome in a subset of chronic lymphocytic leukemia patients. Journal of Clinical Investigation, 118, 306 315.
67. Vargas-Madrazo, E., Lara-Ochoa, F., Ramirez-Benites, M.C. Almagro, J.C. (1997) Evolution of the structural repertoire of the human V(H) and Vkappa germline genes. International Immunology, 9, 1801 1815.
68. Widhopf, G.F., Rassenti, L.Z., Toy, T.L., Gribben, J.G., Wierda, W.G. Kipps, T.J. (2004) Chronic lymphocytic leukemia B cells of more than 1% of patients express virtually identical immunoglobulins. Blood, 104, 2499 2504.
69. Widhopf, G.F., Goldberg, C.J., Toy, T.L., Rassenti, L.Z., Wierda, W.G., Byrd, J.C., Keating, M.J., Gribben, J.G., Rai, K.R. Kipps, T.J. (2008) Nonstochastic pairing of immunoglobulin heavy and light chains expressed by chronic lymphocytic leukemia B cells is predicated on the heavy chain CDR3. Blood, 111, 3137 3144.
70. Yousfi, M.M., Giudicelli, V., Chaume, D. Lefranc, M.P. (2004) IMGT/JunctionAnalysis: the first tool for the analysis of the immunoglobulin and T cell receptor complex V-J and V-D-J JUNCTIONs. Bioinformatics, 20 (Suppl. 1 i379 i385.
71. Zenz, T., Dohner, H. Stilgenbauer, S. (2007) Genetics and risk-stratified approach to therapy in chronic lymphocytic leukemia. Best Practice & Research. Clinical Haematology, 20, 439 453.